Sharon Jones, a research nurse in dermatology and one of the new Faculty members said, 'This new initiative is exciting for research nurses like me. The Faculty will offer the support and collaboration necessary to translate new information into actual patient benefit, in terms of gentler and more effective therapies and improved diagnosis and prognosis. The new clinical research facilities will enable us to care for research participants in a safe and dignified environment.'
Dr Katie Lacy, a Clinical Research Consultant within the BRC's dermatology theme said, 'The new Faculty will add support to an already flourishing research environment. My research involves investigating new potential treatments for malignant melanoma, a condition for which there are currently very few effective treatments once it has spread from the skin. The assistance provided by the Faculty will help me to ensure that scientific discoveries made in the laboratory can be developed as effective therapies that can be administered to patients as quickly as possible.'
Dr David King, Director, Central Commissioning Facility (CCF) at the National Institute for Health Research, said, 'I welcome the establishment of the Faculty of Translational Medicine, which will support the BRC's mission to drive innovation in the prevention, diagnosis and treatment of ill health and to translate advances in biomedical research into real benefits for patients.'
|Contact: Andrea Ttofa|
King's College London